|
(Health-NewsWire.Net, April 29, 2015 ) Dallas, TX -- This report provides elemental information and data relating to the clinical trials on Becker Muscular Dystrophy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Becker Muscular Dystrophy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Complete report on H1 2015 pipeline review of “Becker Muscular Dystrophy” addiction with 37 market data tables and 22 figures, spread across 69 pages is available at http://www.rnrmarketresearch.com/becker-muscular-dystrophy-global-clinical-trials-review-h1-2015-market-report.html . (This is a premium report price at US$2500 for a single user PDF license)
Scope:
• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)
Inquire for discount on this report at http://www.rnrmarketresearch.com/contacts/discount?rname=312758 .
Reasons to Buy:
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
• Understand the dynamics of a particular indication in a condensed manner
Table of Contents:
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Becker Muscular Dystrophy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
More reports on Clinical Trial :
Hematological Tumor Global Clinical Trials Review, H1, 2015
GlobalData’s clinical trial report, “Hematological Tumor Global Clinical Trials Review, H1, 2015″ provides data on the Hematological Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematological Tumor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hematological Tumor.
Complete report is available at http://www.rnrmarketresearch.com/hematological-tumor-global-clinical-trials-review-h1-2015-market-report.html .
RnR Market Research
Ritesh Tiwari
+ 1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
